IMTX
Price
$5.23
Change
+$0.22 (+4.39%)
Updated
May 2 closing price
Capitalization
635.71M
17 days until earnings call
MRUS
Price
$44.19
Change
-$1.26 (-2.77%)
Updated
May 2 closing price
Capitalization
3.06B
10 days until earnings call
Ad is loading...

IMTX vs MRUS

Header iconIMTX vs MRUS Comparison
Open Charts IMTX vs MRUSBanner chart's image
Immatics
Price$5.23
Change+$0.22 (+4.39%)
Volume$699.05K
Capitalization635.71M
Merus
Price$44.19
Change-$1.26 (-2.77%)
Volume$705.64K
Capitalization3.06B
IMTX vs MRUS Comparison Chart
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. MRUS commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and MRUS is a Buy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (IMTX: $5.23 vs. MRUS: $44.19)
Brand notoriety: IMTX and MRUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 106% vs. MRUS: 92%
Market capitalization -- IMTX: $635.71M vs. MRUS: $3.06B
IMTX [@Biotechnology] is valued at $635.71M. MRUS’s [@Biotechnology] market capitalization is $3.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileMRUS’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • MRUS’s FA Score: 1 green, 4 red.
According to our system of comparison, MRUS is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 5 TA indicator(s) are bullish while MRUS’s TA Score has 5 bullish TA indicator(s).

  • IMTX’s TA Score: 5 bullish, 4 bearish.
  • MRUS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than MRUS.

Price Growth

IMTX (@Biotechnology) experienced а +15.71% price change this week, while MRUS (@Biotechnology) price change was +1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

IMTX is expected to report earnings on Aug 12, 2025.

MRUS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRUS($3.06B) has a higher market cap than IMTX($636M). MRUS YTD gains are higher at: 5.089 vs. IMTX (-26.442). IMTX has higher annual earnings (EBITDA): -36.26M vs. MRUS (-269.6M). MRUS has more cash in the bank: 537M vs. IMTX (491M). MRUS has less debt than IMTX: MRUS (9.91M) vs IMTX (16M). IMTX has higher revenues than MRUS: IMTX (116M) vs MRUS (36.1M).
IMTXMRUSIMTX / MRUS
Capitalization636M3.06B21%
EBITDA-36.26M-269.6M13%
Gain YTD-26.4425.089-520%
P/E Ratio31.42N/A-
Revenue116M36.1M321%
Total Cash491M537M91%
Total Debt16M9.91M161%
FUNDAMENTALS RATINGS
IMTX vs MRUS: Fundamental Ratings
IMTX
MRUS
OUTLOOK RATING
1..100
2259
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
8791
PRICE GROWTH RATING
1..100
6045
P/E GROWTH RATING
1..100
46100
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRUS's Valuation (60) in the Biotechnology industry is in the same range as IMTX (66) in the null industry. This means that MRUS’s stock grew similarly to IMTX’s over the last 12 months.

MRUS's Profit vs Risk Rating (30) in the Biotechnology industry is significantly better than the same rating for IMTX (100) in the null industry. This means that MRUS’s stock grew significantly faster than IMTX’s over the last 12 months.

IMTX's SMR Rating (87) in the null industry is in the same range as MRUS (91) in the Biotechnology industry. This means that IMTX’s stock grew similarly to MRUS’s over the last 12 months.

MRUS's Price Growth Rating (45) in the Biotechnology industry is in the same range as IMTX (60) in the null industry. This means that MRUS’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for MRUS (100) in the Biotechnology industry. This means that IMTX’s stock grew somewhat faster than MRUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXMRUS
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 30 days ago
80%
Bearish Trend 1 day ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PASTX43.80N/A
N/A
T. Rowe Price Science & Tech Adv
PCSMX13.29N/A
N/A
Principal SmallCap Growth I R6
ACMTX9.59N/A
N/A
AB All Market Real Return C
BGFRX11.29N/A
N/A
William Blair Growth R6
LFLTX13.00N/A
N/A
Lord Abbett Focused Large Cap Value R5

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with RCKT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+4.39%
RCKT - IMTX
44%
Loosely correlated
+1.91%
MRUS - IMTX
44%
Loosely correlated
-2.77%
CGON - IMTX
42%
Loosely correlated
+4.72%
ACLX - IMTX
42%
Loosely correlated
+0.03%
ROIV - IMTX
42%
Loosely correlated
-0.86%
More

MRUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with CGON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-2.77%
CGON - MRUS
45%
Loosely correlated
+4.72%
ACLX - MRUS
43%
Loosely correlated
+0.03%
IMTX - MRUS
42%
Loosely correlated
+4.39%
RCKT - MRUS
41%
Loosely correlated
+1.91%
ELVN - MRUS
40%
Loosely correlated
+3.32%
More